Gustavo Cabrera

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Alberto Ortíz, Ademola K. Abiose, Daniel G. Bichet et al. · Journal of Medical Genetics · 2016 · 147 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +10

Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry

Dominique P. Germain, Frank Weidemann, Ademola K. Abiose et al. · Genetics in Medicine · 2013 · 92 citations · Full text

Medicine, Cardiology, Internal Medicine +8

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Robert Zangerle, Giota Touloumi, Josiane Warszawski et al. · Clinical Infectious Diseases · 2017 · 62 citations · Full text

Public Health, Health Sciences, Infectious Diseases +12

Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry

Robert J. Hopkin, Gustavo Cabrera, Joel Charrow et al. · Molecular Genetics and Metabolism · 2016 · 55 citations · Full text

Medicine, Cardiology, Clinical Sciences +15

Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis.

C Collawn, Peter Rubin, Jaime Fernández de Bobadilla et al. · PubMed · 1992 · 48 citations

Medicine, Pharmacology, Pharmacotherapy +16